Duohexabody-CD37, a Novel Bispecific Antibody with a Hexamerization-Enhancing Mutation Targeting CD37, Demonstrates Superior Complement-Dependent Cytotoxicity in Preclinical B-Cell Malignancy Models

Author(s):
Oostindie, S.C.; Horst, H.J. van der; Overdijk, M.B.; Strumane, K.; Verploegen, S.; Lindorfer, M.A.; Cook, E.M.; Chamuleau, M.E.D.; Mutis, T.; Schuurman, J.; Sasser, A.K.; Taylor, R.P.; Parren, P.W.H.I. (0000-0002-4365-3859); Beurskens, F.J.; Breij, E.C.W.
Published
2018
Publication type
Other
Date issued
2018-11-29
Language
English
Publisher
AMER SOC HEMATOLOGY
hdl
1887/121521
doi
10.1182/blood-2018-99-114723